Cormorant Asset Management LP 13D and 13G filings for AVEO Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 3:07 pm Sale | 2020-12-31 | 13G | AVEO Pharmaceuticals, Inc. AVEO | Cormorant Asset Management LP | 0 0.000% | -1,350,000 (Position Closed) | Filing |
| 2020-06-29 5:22 pm Unchanged | 2020-06-17 | 13G | AVEO Pharmaceuticals, Inc. AVEO | Cormorant Asset Management LP | 1,350,000 5.230% | 0 (Unchanged) | Filing |
| 2020-06-29 5:22 pm Purchase | 2020-06-17 | 13G | AVEO Pharmaceuticals, Inc. AVEO | Cormorant Asset Management LP | 1,350,000 5.230% | 1,350,000 (New Position) | Filing |